ReviewEndocrine2016
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
Nicola Ferri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papertrialcites it